Page last updated: 2024-10-19

melatonin and Dyspnea

melatonin has been researched along with Dyspnea in 3 studies

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"Dyspnea was improved by melatonin (P=0."2.77Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study. ( Andrade, GM; Cavalcante, MM; de Bruin, PF; de Bruin, VM; de Matos Cavalcante, AG; Nunes, DM; Pereira, ED, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Wang, XC1
Wu, GL1
Cai, YF1
Zhang, SJ1
de Matos Cavalcante, AG1
de Bruin, PF1
de Bruin, VM1
Nunes, DM1
Pereira, ED1
Cavalcante, MM1
Andrade, GM1
Cagnoni, ML1
Lombardi, A1
Cerinic, MC1
Dedola, GL1
Pignone, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effects of Oral Melatonin on Neurosensory Recovery Following Facial Osteotomies - A Randomised, Controlled Clinical Trial[NCT02889432]Phase 240 participants (Anticipated)Interventional2016-06-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for melatonin and Dyspnea

ArticleYear
The safety and efficacy of melatonin in the treatment of COVID-19: A systematic review and meta-analysis.
    Medicine, 2022, Sep-30, Volume: 101, Issue:39

    Topics: C-Reactive Protein; Cough; COVID-19 Drug Treatment; Dyspnea; Humans; Melatonin; SARS-CoV-2

2022

Trials

1 trial available for melatonin and Dyspnea

ArticleYear
Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study.
    Journal of pineal research, 2012, Volume: 53, Issue:3

    Topics: Aged; Aged, 80 and over; Antioxidants; Dinoprost; Double-Blind Method; Dyspnea; Female; Humans; Lung

2012

Other Studies

1 other study available for melatonin and Dyspnea

ArticleYear
Melatonin for treatment of chronic refractory sarcoidosis.
    Lancet (London, England), 1995, Nov-04, Volume: 346, Issue:8984

    Topics: Adult; Chronic Disease; Dyspnea; Female; Humans; Lung Diseases; Melatonin; Middle Aged; Sarcoidosis;

1995